NETRIS Pharma, a clinical-stage immuno-oncology pharmaceutical company pioneering dependence receptors-based drug discovery and development, is confirming that :
- CEO and Founder Patrick Mehlen,
- CMO Frédéric Le Bras, and
- CFO Christophe Guichard,
will be attending the ESMO Congress taking place September 9-13, 2022, in Paris. Come and meet with us !
For any information, please send an email to email@example.com
All details at : https://www.esmo.org/meetings/esmo-congress-2022